Schluter, Daniela K, Ostrenga, Josh S, Carr, Siobhan B, Fink, Aliza K, Faro, Albert, Szczesniak, Rhonda D, Keogh, Ruth H, Charman, Susan C, Marshall, Bruce C, Goss, Christopher H et al (show 1 more authors)
(2022)
Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data
THORAX, 77 (2).
pp. 136-142.
ISSN 0040-6376, 1468-3296
|
Text
thoraxjnl-2021-216849.full.pdf - Published version Download (1MB) | Preview |
Abstract
Rationale A previous analysis found significantly higher lung function in the US paediatric cystic fibrosis (CF) population compared with the UK with this difference apparently decreasing in adolescence and adulthood. However, the cross-sectional nature of the study makes it hard to interpret these results. Objectives To compare longitudinal trajectories of lung function in children with CF between the USA and UK and to explore reasons for any differences. Methods We used mixed effects regression analysis to model lung function trajectories in the study populations. Using descriptive statistics, we compared early growth and nutrition (height, weight, body mass index), infections (Pseudomonas aeruginosa, Staphylococcus aureus) and treatments (rhDnase, hypertonic saline, inhaled antibiotics). Results We included 9463 children from the USA and 3055 children from the UK with homozygous F508del genotype. Lung function was higher in the USA than in the UK when first measured at age six and remained higher throughout childhood. We did not find important differences in early growth and nutrition, or P.aeruginosa infection. Prescription of rhDNase and hypertonic saline was more common in the USA. Inhaled antibiotics were prescribed at similar levels in both countries, but Tobramycin was prescribed more in the USA and colistin in the UK. S. aureus infection was more common in the USA than the UK. Conclusions Children with CF and homozygous F508del genotype in the USA had better lung function than UK children. These differences do not appear to be explained by early growth or nutrition, but differences in the use of early treatments need further investigation.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | cystic fibrosis, paediatric lung disaese, clinical epidemiology |
| Divisions: | Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Population Health |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 12 May 2021 08:15 |
| Last Modified: | 23 May 2026 05:52 |
| DOI: | 10.1136/thoraxjnl-2021-216849 |
| Related Websites: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3122422 |
| Disclaimer: | The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate. |
Altmetric
Altmetric